Last reviewed · How we verify
nitrite
At a glance
| Generic name | nitrite |
|---|---|
| Sponsor | University of Washington |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Urine and Ultrasound Screening for Kidney Disease in Children (NA)
- The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
- Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy (NA)
- Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure. (EARLY_PHASE1)
- Dietary Nitrate and the Oral Microbiome in Children With Primary Hypertension
- Do Dynamic Urinary Leukocyte and Nitrite Changes Improve Risk Prediction for Infectious Complications Following PCNL?
- Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19) (PHASE1)
- Effects of Sustained-release Oral Sodium Nitrite on Postoperative Pain and Recovery Following Total Knee Arthroplasty (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- nitrite CI brief — competitive landscape report
- nitrite updates RSS · CI watch RSS
- University of Washington portfolio CI